S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Sanntidsoppdatering for Hypera S.A. [HYPMY]

Børs: OTC Sektor: Healthcare Industri: Drug Manufacturers—Specialty & Generic
Sist oppdatert3 mai 2024 @ 20:49

3.46% $ 5.94

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 20:49):

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands...

Stats
Dagens volum 15 275.00
Gjennomsnittsvolum 10 345.00
Markedsverdi 3.76B
EPS $0.782 ( 2023-09-30 )
Neste inntjeningsdato ( $0 ) 2024-07-25
Last Dividend $0.0640 ( 2023-07-06 )
Next Dividend $0 ( N/A )
P/E 11.64
ATR14 $0 (0.00%)

Hypera S.A. Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Hypera S.A. Økonomi

Annual 2023
Omsetning: $7.91B
Bruttogevinst: $4.85B (61.30 %)
EPS: $2.61
FY 2023
Omsetning: $7.91B
Bruttogevinst: $4.85B (61.30 %)
EPS: $2.61
FY 2022
Omsetning: $7.55B
Bruttogevinst: $4.76B (63.10 %)
EPS: $2.68
FY 2021
Omsetning: $5.94B
Bruttogevinst: $3.80B (64.05 %)
EPS: $2.11

Financial Reports:

No articles found.

Hypera S.A. Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0.0590
(N/A)
$0.117
(N/A)
$0
(N/A)
$0.0590
(N/A)
$0.0640
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

Hypera S.A. Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.91%) | Divividend Growth Potential Score: 5.91 - Stable (18.26%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0770 2011-05-10
Last Dividend $0.0640 2023-07-06
Next Dividend $0 N/A
Payout Date 2023-09-09
Next Payout Date N/A
# dividends 30 --
Total Paid Out $2.45 --
Avg. Dividend % Per Year 0.00% --
Score 4.13 --
Div. Sustainability Score 9.59
Div.Growth Potential Score 5.91
Div. Directional Score 7.75 --
Next Divdend (Est)
(2024-10-23)
$0.0654 Estimate 12.14 %
Dividend Stability
0.49 Below Average
Dividend Score
4.13
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSBQ Ex Dividend Junior 2023-07-06 Annually 0 0.00%
EBBNF Ex Dividend Knight 2023-08-14 Quarterly 0 0.00%
VONOY No Dividend Player 2023-05-26 Annually 0 0.00%
KGSPY Ex Dividend Knight 2023-09-07 Semi-Annually 0 0.00%
BOSSY Ex Dividend Junior 2023-05-10 Annually 0 0.00%
SBOEY Ex Dividend Junior 2023-05-23 Sporadic 0 0.00%
FFWC Ex Dividend Knight 2023-09-14 Quarterly 0 0.00%
MCRAB Ex Dividend Knight 2023-09-20 Quarterly 0 0.00%
CKHUY Ex Dividend Knight 2023-09-01 Semi-Annually 0 0.00%
STBI Ex Dividend Knight 2023-08-14 Quarterly 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.2121.5005.778.65[0 - 0.5]
returnOnAssetsTTM0.06041.2007.999.58[0 - 0.3]
returnOnEquityTTM0.1491.5009.4510.00[0.1 - 1]
payoutRatioTTM0.0801-1.0009.20-9.20[0 - 1]
currentRatioTTM1.8070.8005.974.77[1 - 3]
quickRatioTTM1.3140.8006.985.58[0.8 - 2.5]
cashRatioTTM0.6621.5007.4310.00[0.2 - 2]
debtRatioTTM0.378-1.5003.69-5.54[0 - 0.6]
interestCoverageTTM2.281.000-0.266-0.266[3 - 30]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
freeCashFlowPerShareTTM1.8662.009.0710.00[0 - 20]
debtEquityRatioTTM0.910-1.5006.36-9.54[0 - 2.5]
grossProfitMarginTTM0.6151.0003.093.09[0.2 - 0.8]
operatingProfitMarginTTM0.3271.0005.455.45[0.1 - 0.6]
cashFlowToDebtRatioTTM0.1831.000-0.0935-0.0935[0.2 - 2]
assetTurnoverTTM0.2860.800-1.429-1.143[0.5 - 2]
Total Score9.59

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM11.191.0008.970[1 - 100]
returnOnEquityTTM0.1492.509.6510.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.8662.009.3810.00[0 - 30]
dividendYielPercentageTTM0.1781.5005.560[0 - 0.4]
operatingCashFlowPerShareTTM3.082.008.9710.00[0 - 30]
payoutRatioTTM0.08011.5009.20-9.20[0 - 1]
pegRatioTTM0.03941.500-3.070[0.5 - 2]
operatingCashFlowSalesRatioTTM0.2431.0006.430[0.1 - 0.5]
Total Score5.91

Hypera S.A.

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides dermo-cosmetics products under the Mantecorp Skincare brands; and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and similar and generic medicines under the Neo Química, Sodium Diclofenac, Hydroxyzine, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. is based in São Paulo, Brazil.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.